China is issuing more licenses to its global partners to locally produce Chinese-developed vaccines. Licensing enables overseas partners to secure fast access to vaccines, and sometimes boosts them to become a supply center in their own region and beyond, proof of China's commitment in promoting vaccine accessibility, analysts said. Editor: Hu Yuwei, Yang Ruoyu, Tu Jiayu(intern)/GT Graphic: Xu Zihe/GT